![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessSystemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study
The epidemiology and clinical presentation of systemic juvenile idiopathic arthritis (sJIA) in the Afro-Caribbean population is not well described.
-
Article
Open AccessProceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
-
Article
Open AccessProceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
-
Article
Open AccessProceedings of the 23rd Paediatric Rheumatology European Society Congress: part three
-
Article
Open AccessProbable DRESS syndrome induced by IL-1 inhibitors
Interleukin (IL)-1 inhibitors have been increasingly used for treating autoinflammatory diseases during the last 10 years, but the spectrum of their possible side effects is not yet fully known. Here, we bring...
-
Article
Open AccessEvidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
Macrophage activation syndrome (MAS) is a severe and potentially lethal complication of several inflammatory diseases but seems particularly linked to systemic juvenile idiopathic arthritis (sJIA). Standardize...
-
Article
Open AccessGenetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency
-
Article
Open AccessFrench Amyloidosis CAPS study: AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 14 cases and review of 53 cases from literature
-
Article
Open AccessCost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
-
Article
Open AccessLong term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
-
Article
Open Access“Daily life of CAPS patients treated with canakinumab (Ilaris®) : data from the French observational study - ENVOL Study”
-
Article
Open AccessThe RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS)
-
Article
Open AccessEfficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis
-
Article
Open AccessUse of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
-
Article
Open AccessMaintenance of efficacy of canakinumab in SJIA at the individual patient level in a 12-week pooled dataset
-
Article
Open AccessPReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis
-
Article
Open AccessPReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
-
Article
Open AccessPReS13-SPK-1030: Juvenile dermatomyositis
-
Article
Open AccessPReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics
-
Article
Open AccessPReS-FINAL-2191: Imaging of chronic recurrent multifocal osteitis: a french national cohort of 178 cases